These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9464359)

  • 1. Design of N-acylprolyltyrosine "tripeptoid" analogues of neurotensin as potential atypical antipsychotic agents.
    Gudasheva TA; Voronina TA; Ostrovskaya RU; Zaitseva NI; Bondarenko NA; Briling VK; Asmakova LS; Rozantsev GG; Seredenin SB
    J Med Chem; 1998 Jan; 41(3):284-90. PubMed ID: 9464359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].
    Ostrovskaia RU; Retiunskaia MV; Guzevatykh LS; Gudasheva TA; Voronina TA; Seredin SB
    Eksp Klin Farmakol; 2005; 68(1):3-6. PubMed ID: 15786954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-substituted-1,2-benzisoxazoles: novel antipsychotic agents.
    Davis L; Effland RC; Klein JT; Dunn RW; Geyer HM; Petko WW
    Drug Des Discov; 1992 Feb; 8(3):225-40. PubMed ID: 1356026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The search of small molecules with antipsychotic activity on the background of neurotensin].
    Ostrovskaia RU; Gudasheva TA; Krupina NA; Seredin SB
    Bioorg Khim; 2012; 38(1):119-26. PubMed ID: 22792715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
    Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
    Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decrease in the glutamate release may contribute to the neuroprotective action of the novel neuroleptic drug dilept].
    Us KS; Klodt PM; Kudrin VS; Arkhipenko NV; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2007; 70(3):3-5. PubMed ID: 17650623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
    Asmakova LS; Kalinina TS; Ostrovskaya RU; Gudasheva TA; Zaitseva NI; Bondarenko NA; Voronina TA; Seredenin SB
    Pharmacol Biochem Behav; 1999 Oct; 64(2):359-62. PubMed ID: 10515313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents.
    Kelley JL; Bullock RM; Krochmal MP; McLean EW; Linn JA; Durcan MJ; Cooper BR
    J Med Chem; 1997 Sep; 40(20):3207-16. PubMed ID: 9379440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The new tripeptoid neurotensin analog dilept selectively affects dopamine turnover in nucleus accumbens and hypothalamus].
    Retiunskaia MV; Kudrin VS; Klodt PM; Us KS; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2005; 68(6):15-8. PubMed ID: 16405028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
    Feifel D; Reza TL; Wustrow DJ; Davis MD
    J Pharmacol Exp Ther; 1999 Feb; 288(2):710-3. PubMed ID: 9918579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
    J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs.
    Nakazato A; Ohta K; Sekiguchi Y; Okuyama S; Chaki S; Kawashima Y; Hatayama K
    J Med Chem; 1999 Mar; 42(6):1076-87. PubMed ID: 10090790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.
    Sauerberg P; Jeppesen L; Olesen PH; Rasmussen T; Swedberg MD; Sheardown MJ; Fink-Jensen A; Thomsen C; Thøgersen H; Rimvall K; Ward JS; Calligaro DO; DeLapp NW; Bymaster FP; Shannon HE
    J Med Chem; 1998 Oct; 41(22):4378-84. PubMed ID: 9784113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics.
    Kumar S; Wahi AK; Singh R
    Eur J Med Chem; 2011 Sep; 46(9):4753-9. PubMed ID: 21824691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.